?

Reed John C

EVP, Innovative Medicine, R&D
Johnson & Johnson
US, New Brunswick [HQ]
CIK 1181561

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
225,610,000
Price per Share :
$147.03
Equivalence :
$33,171,438,300.00

Transaction History

  • M
    Form 4
    225,610,000 Shares After Transaction
    Value : $n/a
    $0.0
    05/01/24
  • Footnotes:
    #1 The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.
    #2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
  • F
    Form 4
    115,770,000 Shares After Transaction
    Value : $16,739,184,300.00
    $15,881,765,600.00
    05/01/24